Paclitaxel-induced dorsal hand-foot syndrome.

Hand-foot syndrome (HFS), also known as palmoplantar erythrodysesthesia or acral erythema, is a known adverse effect of chemotherapeutic agents that most commonly presents as palmoplantar dysesthesia and erythematous plaques localized to the palms and soles. Paclitaxel is an uncommon cause of HFS and is notable for its unique presentation on the dorsal hands and feet. We present an unusual case of paclitaxel-induced HFS localized to the dorsal hands of a 66-year-old man with metastatic angiosarcoma. Early identification and management of HFS is critical to allow for continuation of chemotherapy while improving patient quality of life.

Citation

Eugenie Y Quan, Casey Engel, Patrick S Rush, Joshua D Eikenberg. Paclitaxel-induced dorsal hand-foot syndrome. Dermatology online journal. 2023 Jun 15;29(3)

Mesh Tags

Substances

PMID: 37591274

search → result